| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |